Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older than 70 Years; Survival Benefit at Considerable Morbidity and Mortality: A Reply

from Cancer via ola Kala on Inoreader http://ift.tt/2j2IuyS
via IFTTT